On August 19, 2022 (Closing), Organicell Regenerative Medicine, Inc. consummated its previously announced $4.0 million capital raise and corporate restructuring transaction. At Closing, Albert Mitrani, Dr. Allen Meglin and Michael Carbonara stepped down as directors of the Company. It is anticipated that additional directors will be appointed to the board, the majority of whom will be independent in accordance with the rules and regulations of the SEC and the Nasdaq Stock Market, LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.95 USD | -5.00% | -5.94% | -6.86% |
03-18 | Zeo ScientifiX, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
03-05 | Zeo ScientifiX, Inc. has Changed its Ticker to ZEOX from OCEL | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.86% | 5.82M | |
+23.03% | 74.04B | |
-1.52% | 24.18B | |
+3.67% | 8.46B | |
+8.55% | 8.34B | |
-23.71% | 7.64B | |
+15.20% | 5.33B | |
-6.90% | 3.92B | |
+2.68% | 4.12B | |
+5.56% | 3.89B |
- Stock Market
- Equities
- ZEOX Stock
- News Zeo ScientifiX, Inc.
- Organicell Regenerative Medicine, Inc. Announces Board Changes